Bovi-Shield^® GOLD 5

Vaccine

A freeze-dried preparation of modified live virus strains of Infectious Bovine Rhinotracheitis (IBR) virus, Bovine Viral Diarrhoea (BVD Type 1 and 2), Parainfluenza 3 (PI₃) and Bovine Respiratory Syncytial Virus (BRSV) viruses, plus a sterile diluent used to re-hydrate the freeze-dried vaccine.

Viral antigens are propagated on established cell lines

Bovi-Shield^® GOLD 5 is recommended for vaccination of healthy cattle as an aid in preventing disease caused by IBR, BVD Type 1 and 2, PI₃ and BRSV. Bovi-Shield^® GOLD 5 may be administered to pregnant cattle provided they were vaccinated with any Bovi-Shield FP product, according to their label directions, with the last vaccination within the last 12 months. It may also be administered to calves nursing pregnant cows provided their dams were vaccinated within the past 12 months with any Bovi-Shield FP product.

Vaccination of healthy cattle is recommended. Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided, shake well and administer 2 ml intramuscularly, in the muscular region of the neck.

Primary Vaccination: Administer a single 2 ml dose to healthy cattle, followed by a second dose of Bovi-Shield^® GOLD 5, 3–4 weeks later.

Revaccination: Annual revaccination with a single dose is recommended.

Do not vaccinate within 21 days before slaughter. Keep out of reach of children and uninformed persons.

For veterinary use only.

Contains gentamicin as a preservative.

Do not use in pregnant cows, unless they were vaccinated with any Bovi-Shield FP product within the past 12 months.

This vaccine has been shown to be efficacious in healthy animals. A protective immune response may not be elicited:

• if animals are incubating an infectious disease,
• are malnourished or parasitised,
• are stressed due to shipment or environmental conditions,
• are otherwise immuno compromised,
• or the vaccine is not administered in accordance with label directions.

Although this vaccine has been extensively tested under a large variety of conditions, failure thereof may ensue as a result of a wide range of reasons. If this is suspected, seek veterinary advice and notify the registration holder.

Do not use in pregnant cows, unless they were vaccinated with any Bovi-Shield FP product, according to label directions, with the last vaccination within the last 12 months.

Use the entire contents when first opened.

Do not use in calves nursing pregnant cows unless their dams were vaccinated within the past 12 months with any Bovi-Shield FP product. According to label directions sterilized syringes and needles should be used to administer the vaccine. Do not sterilize with chemicals because traces of disinfectant may inactivate the vaccine. Burn containers and all unused contents. If vaccination results in anaphylaxis, an initial antidote of adrenaline or equivalent is recommended, and should be followed with appropriate supportive therapy.

The vaccine should be stored at temperatures between 2 °C - 7 °C, and must be protected from light. Do not freeze.

10 dose vial rehydrated with 20 ml sterile diluent

50 dose vial rehydrated with 100 ml sterile diluent.